You are here

  • Home
  • Archive
  • Volume 3, Issue 1
  • Prevention and control strategies for emergency, limited-term, and elective operations in pediatric surgery during the epidemic period of COVID-19

Article Text

Article menu

Download PDFPDF

Review
Prevention and control strategies for emergency, limited-term, and elective operations in pediatric surgery during the epidemic period of COVID-19
  1. Daxing Tang1,2,
  2. Jinfa Tou1,2,
  3. Jinhu Wang1,2,
  4. Qingjiang Chen1,2,
  5. Wei Wang2,3,
  6. Jinjin Huang2,4,
  7. Hangyan Zhao2,4,
  8. Jia Wei1,2,
  9. Zheming Xu1,2,
  10. Dongyan Zhao1,2,
  11. Junfen Fu2,5 and
  12. Qiang Shu1,2
  1. 1Department of Pediatric Surgery, Children's Hospital, Zhejiang University School of Medicine, Hangzhou, China
  2. 2National Clinical Research Center for Child Health, Hangzhou, China
  3. 3Department of Cardiology, Children's Hospital, Zhejiang University School of Medicine, Hangzhou, China
  4. 4Anesthesiology and Operation Center, Children's Hospital, Zhejiang University School of Medicine, Hangzhou, China
  5. 5Department of Endocrinology, Children's Hospital, Zhejiang University School of Medicine, Hangzhou, China
  1. Correspondence to Dr Qiang Shu; shuqiang{at}zju.edu.cn

Abstract

The outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread to more than 100 countries. Children approved to be susceptible to SARS-CoV-2 infection. Preventing and controlling the epidemic while ensuring orderly flows of pediatric surgery clinical work has proven to be a big challenge for both patients and clinicians during the epidemic. Based on the transmission characteristics of SARS-CoV-2 and the requirements for prevention and control of COVID-19, the authors proposed some concrete measures and practical strategies of managing emergency, limited-term, and elective pediatric surgeries during the epidemic period.

  • epidemiology
  • paediatric surgery
http://creativecommons.org/licenses/by-nc/4.0/

This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.

https://doi.org/10.1136/wjps-2020-000122

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Contributors DT, JT, JW, CQ and WW proposed the work and wrote the strategy formulation of the article. JH, HZ, JW, ZX, DZ and JF wrote the rest of the article. QS is the guarantor of the article.

    • Funding This article was supported by Zhejiang University special scientific research fund for COVID-19 prevention and control.

    • Competing interests None declared.

    • Patient consent for publication Not required.

    • Ethics approval Not required for this review article.

    • Provenance and peer review Not commissioned; externally peer reviewed.

    • Data availability statement Data sharing not applicable as no datasets generated and/or analyzed for this study.